Analyst PT cluster $50-72 Strong Buy/Zacks revisions
Key Questions
What are the latest analyst price targets for Devon Energy (DVN)?
Recent targets include Wells Fargo at $68, Morgan Stanley at $66, Citi at $65, Jefferies at $63, and Bernstein at $59. The consensus price target stands above $59 with a range of $50-72.
What is the overall analyst rating for DVN stock?
Devon Energy holds a Strong Buy rating, with 88.5% of analysts recommending it. The average rating is overweight with a mean price target around $60.25.
How has Zacks revised its Q1 EPS estimate for Devon Energy?
Zacks raised the Q1 EPS forecast from $0.91 to $0.99, reflecting a 6.4% increase in 30-day revisions. This update follows heightened investor interest in the stock on Zacks.com.
Which firms recently raised their price targets on Devon Energy?
Morgan Stanley lifted its target to $66, Citi increased it to $65 from $60, and Jefferies raised it to $63 from $62. Bernstein also upgraded its target to $59 with an outperform rating.
Why is Devon Energy frequently searched on Zacks?
DVN has become one of the most searched stocks on Zacks.com due to multiple analyst upgrades and price target increases. The stock's performance in the S&P 500 energy sector has also drawn attention.
What is Wells Fargo's stance on Devon Energy?
Wells Fargo maintains a Buy rating on DVN with a $68 price target. This aligns with the broader cluster of positive analyst coverage.
How does the recent analyst activity position Devon Energy among energy stocks?
DVN is highlighted as a top pick among large-cap E&Ps, with analysts noting company rejuvenation. It is included among five energy stocks expected to see further gains after the sector rose 33% this year.
What recent institutional activity has occurred with Devon Energy shares?
Firms like Bull Harbor Capital and iA Financial Group have added or increased positions in DVN. This follows a series of positive analyst calls and target adjustments.
Wells Fargo PT $68; Jefferies $63 (overweight); Bernstein $59 (outperform); Citi $65 (Buy); Morgan Stanley raised to $66. Zacks raised Q1 EPS estimate from $0.91 to $0.99 (+6.4% 30-day revisions). Consensus PT $59+, Strong Buy 88.5% of ratings.